Effects of LP28 on Immunity Enhancement in the Elderly — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effects of LP28 on Immunity Enhancement in the Elderly — Stella

Recruiting

Back to Common Cold trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Taiwan

National Chung Hsing University, Taichung

Taichung Veterans General Hospital, Taichung

Key details

Sponsor

Synbio Tech Inc.

Enrollment target

~100 participants

Started

July 2024

Primary completion

June 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

50 Years – 75 Years

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov